Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells

Fig. 1

a Relaxant effect of glycopyrronium and indacaterol in human isolated bronchi submaximally contracted (EC70) with acetylcholine (a) and histamine (d). Expected and observed relaxant response induced by glycopyrronium and indacaterol in human isolated bronchi submaximally pre-contracted (EC70) with acetylcholine (b) and histamine (e), as predicted by the Bliss Independence theory for the whole range of EC (% Emax). The isoeffective concentrations of glycopyrronium and indacaterol have been indicated below the X-axis. c Delta effect between observed and expected relaxant response induced by glycopyrronium and indacaterol in human isolated bronchi submaximally pre-contracted with acetylcholine (EC70), as predicted by the Bliss Independence theory for the whole range of EC (% Emax). The isoeffective concentrations of glycopyrronium and indacaterol have been indicated below the X-axis. Data are expressed as mean ± SEM from experiments performed using samples from n = 3 different subjects. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. expected relaxant response (statistical significance assessed by t test analysis). ECn: dose inducing n% maximal effect; Emax: maximal effect; GLY: glycopyrronium bromide; IND: indacaterol fumarate

Back to article page